Clarinex

   
Google
 
Web NewDrugInformation.com

Clarinex


Drug - Clarinex
The trade name of the product as shown on the labeling.

Dosage - TABLET, ORALLY DISINTEGRATING; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Desloratadine
Multiple ingredients are in alphabetical order.

Strength - 5MG
The potency of the active ingredient(s), Desloratadine. May repeat for multiple part products.

Applicant - SCHERING
The firm name holding legal responsibility for Clarinex. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021312
The FDA assigned number to Clarinex. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Clarinex. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 26, 2002
The date Clarinex was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Clarinex. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Clarinex is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schering Corp
The full name of the firm holding legal responsibility for the new application of Clarinex.

Clarinex